Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2003
06/17/2003US6579885 For therapy of attention deficit disorder, hyperactivity disorder, anxiety, depression, post-traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, Parkinsonism
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579874 Substituted azoles
06/17/2003US6579873 Treatment of inflammation, arthritis, bone disorders, respiratory system disorders
06/17/2003US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins
06/17/2003US6579718 For detecting and quantifying peptides, polypeptides and proteins; sensitive, facile and does not require use of organic solvents
06/17/2003US6579328 Preparation from a sterically hindered nitroxy compound and a diazonium salt of an aromatic amine in the presence of a transition metal catalyst
06/12/2003WO2003048158A1 Glycinamides as factor xa inhibitors
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048155A1 Thrombin inhibitors
06/12/2003WO2003048154A1 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
06/12/2003WO2003048153A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
06/12/2003WO2003048152A2 Inflammation modulators
06/12/2003WO2003048133A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
06/12/2003WO2003048130A2 Peroxisome proliferator activated receptor agonists
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048125A1 Aminotetralin derivatives as muscarinic receptor antagonists
06/12/2003WO2003048124A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
06/12/2003WO2003048081A2 Glycinamides as factor xa inhibitors
06/12/2003WO2003047591A1 Remedies for primary pulmonary hypertension
06/12/2003WO2003047586A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003WO2003047581A1 Acetylene derivatives having mglur 5 antagonistic activity
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047520A2 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
06/12/2003WO2003047516A2 Pyrimidine compounds
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003WO2003047347A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
06/12/2003WO2003032994A3 Novel tri-substituted pyrimidines, method for production and use thereof as medicament
06/12/2003WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors
06/12/2003US20030109706 Serine pretease inhibitors
06/12/2003US20030109704 Long chain hindered amines and compositions stabilized therewith
06/12/2003US20030109703 Antiinflammatory agents; autoimmune disease
06/12/2003US20030109666 Thermosetting resin compositions containing maleimide and/or vinyl compounds
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109545 Their solvates and/or hydrates exhibiting an affinity and a selectivity for arginine-vasopressin V1b receptors or for both V1b and V1a receptors.
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109533 New benzenesulphonamide compounds
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109521 Aryl substituted thiazolidinones and the use thereof
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/12/2003US20030109517 Azacycloalkanone serine protease inhibitors
06/12/2003US20030109516 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108970 Generating antibodies; quantitative analysis
06/12/2003US20030108771 Electroluminescent platinum compounds and devices made with such compounds
06/12/2003CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
06/12/2003CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468846A1 Peroxisome proliferator activated receptor agonists
06/12/2003CA2468525A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers of 4-[4-[(1r)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3s)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
06/12/2003CA2468349A1 Pyrimidine compounds
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318147A1 Novel pyrimidine derivative and novel pyridine derivative
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317446A1 Oxindole derivatives
06/11/2003EP1317445A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
06/11/2003EP1317430A1 (2-azabicyclo 2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
06/11/2003EP1317429A1 Amidine inhibitors of serine proteases
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317266A2 Neuroprotective 2-pyridinamine compositions and related methods
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0966462B1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
06/11/2003CN1423650A Method for producing heterocyclic compounds
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1111159C Thio acid derived monocyclic N-heterocyclics as anticoagulants
06/10/2003US6576764 Reacting 2-aminopyridine compound with N-methyl-1-phenyl-2,2-iminodiethyl-chloride; cyclization
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576639 Such as 4-(8-chloro-3,7-dibromo-6,11-dihydro-5H-benzo(5,6)-cyclohepta(1,2-b)pyridin -11-yl)-1-(4-pyridinylacetyl)piperi-di ne-n1-oxide-n4-oxide
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003CA2245896C A therapeutic agent for renal disease
1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 1080